MedPath
HSA Approval

MOFLOX SOLUTION FOR INFUSION 400 MG/250 ML

SIN17205P

MOFLOX SOLUTION FOR INFUSION 400 MG/250 ML

MOFLOX SOLUTION FOR INFUSION 400 MG/250 ML

March 17, 2025

PHARMAKOE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAKOE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INFUSION, SOLUTION

INTRAVENOUS

Medical Information

J01MA14

Manufacturer Information

PHARMAKOE PTE. LTD.

ANFARM HELLAS S.A.

Active Ingredients

Moxifloxacin HCl eqv Moxifloxacin

400 mg/250 ML

Moxifloxacin

Documents

Package Inserts

Moflox Injection PI.pdf

Approved: March 17, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MOFLOX SOLUTION FOR INFUSION 400 MG/250 ML - HSA Approval | MedPath